Attached files
| file | filename |
|---|---|
| EX-10.18(E) - EX-10.18(E) - NEVRO CORP | nvro-ex1018e_558.htm |
| EX-32.1 - EX-32.1 - NEVRO CORP | nvro-ex321_7.htm |
| EX-31.2 - EX-31.2 - NEVRO CORP | nvro-ex312_6.htm |
| EX-31.1 - EX-31.1 - NEVRO CORP | nvro-ex311_12.htm |
| EX-21.1 - EX-21.1 - NEVRO CORP | nvro-ex211_8.htm |
| EX-10.21(D) - EX-10.21(D) - NEVRO CORP | nvro-ex1021d_658.htm |
| EX-10.18(G) - EX-10.18(G) - NEVRO CORP | nvro-ex1018g_556.htm |
| EX-10.18(F) - EX-10.18(F) - NEVRO CORP | nvro-ex1018f_557.htm |
| EX-10.18(D) - EX-10.18(D) - NEVRO CORP | nvro-ex1018d_559.htm |
| 10-K - 10-K - NEVRO CORP | nvro-10k_20171231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S‑3 (No. 333-211864) and Form S-8 (Nos. 333-216206, 333-209816, 333-202857, and 333-200145) of Nevro Corp. of our report dated February 22, 2018 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
San Jose, California
February 22, 2018